Zdrowie i gospodarka · 3.03.2026
FDA Requests Comments on SUPAC Guidances for Industry
The FDA is soliciting public comments on its SUPAC guidances for industry, specifically on scale-up and postapproval changes for dosage forms, until a specified date.